{"id":7118,"date":"2026-10-22T11:38:56","date_gmt":"2026-10-22T06:08:56","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-22\/"},"modified":"2026-10-22T20:21:20","modified_gmt":"2026-10-22T14:51:20","slug":"sagility-share-price-today-2026-10-22","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-22\/","title":{"rendered":"Sagility Share Price Today: Why SAGILITY Is Rising 2.21% | 22 October 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-witty-phase=\"live\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: SAGILITY<\/strong> \u00b7 22 October 2026<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b945.39<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>+2.21%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b945.65 \/ \u20b943.85<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b944.41<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>3.03 crore<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>22 October 2026 \u00b7 03:30 PM IST<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-takeaways\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Key Takeaways<\/div>\n<div class=\"wt-card-body\">\n<ul class=\"wt-list\">\n<li>Sagility Limited shares moved up 2.21% on Wednesday, trading between an intraday low of \u20b943.85 and a high of \u20b945.65 before settling at \u20b945.39.<\/li>\n<li>Sagility announced the acquisition of Chirok Health LLC to accelerate its provider growth strategy and expand its end-to-end revenue cycle management offerings. Chirok Health brings specialized clinical documentation improvement and medical coding capabilities with an upfront payment of US$20 million.<\/li>\n<li>Trading volume was 2.58 times the 20-day average daily volume.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<h2>Why is Sagility share price rising on 22 October 2026?<\/h2>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">Sagility Limited shares moved up 2.21% on Wednesday, trading between an intraday low of \u20b943.85 and a high of \u20b945.65 before settling at \u20b945.39.<\/p>\n<p class=\"wt-copy\">The broader market experienced downward pressure during the session, with the Nifty falling 0.88%. Meanwhile, the thematic Nifty Pharma sector index edged down marginally by 0.07%, leaving Sagility to outperform both broader indices despite the negative market undertone.<\/p>\n<p class=\"wt-copy\">The stock move follows a flurry of corporate updates from the company, including the announcement of consolidated financial results for the quarter ended September 30, 2026, and a declaration of an interim dividend of \u20b90.15 per share with a record date of October 30, 2026. Additionally, the company recently announced the acquisition of Chirok Health LLC to strengthen its provider segment revenue cycle management capabilities, providing underlying context for investor sentiment alongside its operational earnings release.<\/p>\n<p class=\"wt-copy\">3.03 crore shares traded by 22 October 2026 \u00b7 03:30 PM IST. This compares with a 20-day average daily volume of 1.18 crore shares (2.58 times). The five-day average daily volume was 1.34 crore shares. Separately, the NSE report for 22 October 2026 showed 86.39 lakh shares delivered, representing 28.47% of that day\u2019s traded volume. The same report recorded 66,978 trades.<\/p>\n<\/div>\n<div class=\"wt-likely-reason\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Likely Reason<\/div>\n<div class=\"wt-card-body\"><strong>Positive earnings and corporate updates against a softer broader market<\/strong><\/p>\n<p class=\"wt-copy\">The 2.21% gain occurred on heavy volume that was more than double the 20-day average, coinciding with the release of strong quarterly financial results, an interim dividend announcement, and recent strategic acquisition disclosures.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div class=\"wt-grid wt-grid-news\">\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Acquisition of Chirok Health LLC<\/div>\n<div class=\"wt-card-date\">22 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Sagility announced the acquisition of Chirok Health LLC to accelerate its provider growth strategy and expand its end-to-end revenue cycle management offerings. Chirok Health brings specialized clinical documentation improvement and medical coding capabilities with an upfront payment of US$20 million.<\/p>\n<p class=\"wt-copy\">Strategic acquisitions expand service capabilities, deepen client penetration in specific healthcare verticals, and influence long-term growth vectors.<\/p>\n<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Press Release<\/div>\n<div class=\"wt-card-date\">22 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">a press release dated October 21, 2026, titled &quot;Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health&quot;.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212509_IntimationPressReleasesigned.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">General Updates<\/div>\n<div class=\"wt-card-date\">22 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212037_IntimationChirokAcquisitionsigned.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Earnings \/ operating update<\/div>\n<div class=\"wt-card-date\">22 July 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">a press release dated July 21, 2026, titled &quot;Press release pertaining to the unaudited financial results for the quarter ended June 30, 2026&quot;.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21072026183803_IntimationPressReleaseQ1FY27signed.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Investment \/ acquisition update<\/div>\n<div class=\"wt-card-date\">22 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">a press release dated October 21, 2026, titled &quot;Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health&quot;.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212509_IntimationPressReleasesigned.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<\/div>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid wt-grid-ownership\">\n<div class=\"wt-card\" data-card=\"ownership\" style=\"background:#fff8e8;border:1px solid #ecd39e;border-left:4px solid #cc922c;border-radius:10px\">\n<div class=\"wt-card-title\">Shareholding<\/div>\n<div class=\"wt-card-date\">As of 30 September 2026<\/div>\n<div class=\"wt-card-body\">\n<div class=\"wt-grid wt-grid-metrics\">\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Promoter holding<\/div>\n<div class=\"wt-value\">50.95%<\/div>\n<div class=\"wt-note\">50.95% on 30 June 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">FII\/FPI<\/div>\n<div class=\"wt-value\">10.38%<\/div>\n<div class=\"wt-note\">9.99% on 30 June 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Institutional holding<\/div>\n<div class=\"wt-value\">32.97%<\/div>\n<div class=\"wt-note\">31.41% on 30 June 2026<\/div>\n<\/div>\n<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1737173_13102026055925_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<\/div>\n<h2>Mutual Fund Holdings<\/h2>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Mutual-fund ownership<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Mutual funds held 15.13% on 30 September 2026. This compares with 13.45% on 30 June 2026, a change of +1.68 percentage points.<\/p>\n<p class=\"wt-copy\">The filing reported 33 MF\/UTI holders.<\/p>\n<div class=\"wt-grid wt-grid-funds\">\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">ICICI Prudential Technology Fund<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">15.88 crore shares \u00b7 3.39%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Kotak Small Cap Fund<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">8.70 crore shares \u00b7 1.86%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Canara Robeco Mutual Fund A\/C Canara Robeco Small Cap Fund<\/div>\n<div class=\"wt-card-date\">30 September 2026<\/div>\n<div class=\"wt-card-body\">8.33 crore shares \u00b7 1.78%<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-note wt-source-note\">These are quarterly holdings, rather than purchases or sales on the article date.<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1737173_13102026055925_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<h2>What to Watch Next<\/h2>\n<ul class=\"wt-list\">\n<li>Execution and integration progress regarding the newly acquired Chirok Health LLC.<\/li>\n<li>Performance and client additions through the upcoming Open Enrollment and AEP season.<\/li>\n<li>Sustainability of adjusted EBITDA margins following the Q2 high of 26.3%.<\/li>\n<li>Shareholder response to the upcoming interim dividend record date on October 30, 2026.<\/li>\n<\/ul>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-19\/\">Sagility Share Price Today: Why SAGILITY Is Falling 2.89% | 19 October 2026 \u2014 19 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-06\/\">Why Sagility Shares Are Rising 3.08% Today | 6 October 2026 \u2014 6 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-09-29\/\">Sagility Share Price Falls 2.09% Today: Key Factors &amp; Analysis | 29 September 2026 \u2014 29 September 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/sagility\/\">More Sagility news and dated analysis \u2192<\/a><\/p>\n<aside class=\"wt-cta wt-cta-dark\">\n<div class=\"wt-cta-title\">Looking for Research-Backed Market Opportunities?<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Frequently Asked Questions<\/h2>\n<div class=\"wt-faq\">\n<h3>What is the latest Sagility company news?<\/h3>\n<p class=\"wt-copy\">Sagility announced the acquisition of Chirok Health LLC to accelerate its provider growth strategy and expand its end-to-end revenue cycle management offerings. Chirok Health brings specialized clinical documentation improvement and medical coding capabilities with an upfront payment of US$20 million.<\/p>\n<h3>How strong was Sagility\u2019s trading volume?<\/h3>\n<p class=\"wt-copy\">3.03 crore shares traded, 2.58 times the 20-day average daily volume. The price and volume data are dated 22 October 2026 \u00b7 03:30 PM IST.<\/p>\n<h3>Do the mutual-fund figures show buying today?<\/h3>\n<p class=\"wt-copy\">They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.<\/p>\n<\/div>\n<p><strong>Research &amp; analysis:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><br \/><strong>Reviewed by:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">Mohanish Sanghavi \u2014 SEBI Registered Research Analyst<\/a><\/p>\n<p>Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.<\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-22\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-10-22\/\"}, \"headline\": \"Sagility Share Price Today: Why SAGILITY Is Rising 2.21% | 22 October 2026\", \"description\": \"Sagility share price rose 2.21% to \u20b945.39 today. See why SAGILITY is rising, volume context, company developments and what to watch next.\", \"datePublished\": \"2026-10-22T06:08:56Z\", \"dateModified\": \"2026-10-22T20:21:10.525003+05:30\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"reviewedBy\": {\"@type\": \"Person\", \"name\": \"Mohanish Sanghavi\", \"jobTitle\": \"SEBI Registered Research Analyst\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/sagility-company-news-2026-10-22.jpg\"]}<\/script><!-- wt-article-record:{\"news_events\":[{\"title\":\"Press Release\",\"summary\":\"a press release dated October 21, 2026, titled \\\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health\\\".\",\"source\":\"NSE\",\"published\":\"21-Oct-2026 21:25:15\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212509_IntimationPressReleasesigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 21, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Ma\u2019am, Subject: Press Release With reference to the captioned subject, please find enclosed the Company's press release titled \u201cSagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health \u201d, along with additional information on Chirok Health. This is for your kind information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008 Encl: a\/a Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health Transaction expands provider - focused capabilities in Clinical Documentation Improvement, Coding Audit and Quality Assurance , Revenue Integrity , Value-Based Care Solutions , HCC Coding and Risk Adjustment. Bangalore, 21 October, 2026 \u2013 Sagility, a leading technology and AI-led healthcare operations company focused on improving payer and provider performance, today announced that it has acquired Chirok Health, a provider of Clinical Documentation Improvement (CDI), medical coding, coding quality assurance programs and revenue integrity services for healthcare organizations. The acquisition adds specialized clinical and coding expertise to Sagility\u2019s provider services portfolio, complementing its strengths in revenue cycle management, patient access, analytics, and technology and AI -led healthcare operations. It broadens Sagility\u2019s ability to address evolving provider needs with integrated solutions. Founded with a focus on helping healthcare providers improve documentation quality, coding accuracy, reimbursement outcomes, and financial performance, Chirok Health has established a strong reputation for delivering high-quality clinical and administrative solutions to hospitals and health systems. Chirok also brings a highly specialized team of clinical documentation specialists, coding professionals, auditors, and healthcare subject matter experts further enhancing Sagility's provider-focused domain expertise to support healthcare providers across a broader spectrum of the revenue cycle and clinical operations value chain. \\\"The acquisition of Chirok Health is an important step in Sagility's strategy to build a comprehensive provider -focused services platform. Chirok's leadership in clinical documentation improvement, medical coding, quality assurance programs , and revenue integrity complements our existing capabilities and expands our ability to support healthcare providers across the healthcare value chain by improving operational, clinical and financial outcomes.\u201d said Ramesh Gopalan, Managing Director and Group CEO of Sagility . \u201cTogether with our recent acquisition of CareSeed, this transaction enhances our ability to help healthcare organizations improve quality outcomes, optimize reimbursement, advance value - based care initiatives, and drive meaningful operational transformation through analytics, automation, and AI.\\\" \\\"Joining Sagility represents an exciting next chapter for Chirok Health,\\\" said Kanar Kokoy, Founder and Chief Executive Officer of Chirok Health. \\\"Both organizations share a commitment to clinical excellence, customer service, innovation, and measurable outcomes. Our clients will continue to receive the specialized expertise and high touch support they value today, while gaining access to a broader set of capabilities that can help address evolving operational and financial challenges.\\\" As healthcare providers continue to face increasing reimbursement complexity, talent challenges, and growing value -based care requirements, the combined organization will be positioned to help clients improve financial sustainability, quality outcomes, operational performance, and patient experience. The combination will also create opportunities to deepen existing client relationships, expand the services footprint across both organizations\u2019 client bases, and introduce complementary capabilities that can contribute to the growth of the combined business. Canaccord Genuity LLC served as the exclusive financial advisor to Chirok Health on the transaction. About Sagility Sagility is a healthcare operations partner that helps payers, providers, and pharmacy benefit managers reduce cost, improve quality, and enhance member and provider experiences. With more than 25 years of exclusive focus in healthcare, Sagility combines deep domain expertise with technology and AI -led transformation, embedding analytics, automation, and AI into operations. The company delivers services across the United States, India, the Philippines, Jamaica, and Colombia. For more information, visit https:\/\/sagility.com\/ About Chirok Health Founded in 2020, Chirok Health provides clinical documentation integrity, medical coding, audit and quality assurance, and revenue cycle optimization services. The company supports healthcare organizations across fee -for-service and value -based care models , combining clinical and coding expertise with technology-enabled workflows to strengthen documentation accuracy, compliance, and financial performance. To learn more, visit chirokhealth.com. Media Contact Global Corporate Communications Email: press@sagility.com Acquisition Rationale: Acquiring Chirok Health accelerates Sagility's strategy of building a comprehensive provider- focused services platform by adding specialized clinical documentation, medical coding and coding quality assurance to bolster its mid-revenue cycle capabilities. The transaction deepens Sagility's clinical domain expertise, expands its addressable market across providers and payers, and creates new opportunities to drive revenue growth through integrated clinical and revenue cycle solutions. 1. Strengthens Sagility's Provider end-to-end Revenue Cycle services Expands Sagility's capabilities across Clinical Documentation Improvement (CDI), medical coding and coding QA enhancing Sagility\u2019s ability to serve health systems, physician groups, and value -based care organizations. Chirok\u2019s mid -revenue cycle solutions a re a natural complement to Sagility\u2019s proven front -end and back -end revenue cycle offerings, helping Sagility generate improved financial and operational outcomes for healthcare providers from patient access through final payment. 2. Accelerates Cross-Sell and Revenue Growth Opportunities The acquisition creates significant cross-selling opportunities across both organizations' client bases by introducing Sagility's broader analytics, AI and automation driven RCM services to Chirok clients while also offering Chirok's solutions to current Sagility provider and payer customers. The combined organization is well positioned to deepen client relationships, expand services footprint and generate increased operating synergies an d value for current and future clients. 3. Expands Value-Based Care and Payer Opportunities Chirok enhances Sagility\u2019s capabilities in risk adjustment creating a more comprehensive offering for risk -bearing providers and health plans. Combining these capabilities with Sagility's care management, care coordination, and care -gap closure offerings c reates differentiated solutions. 4. Strategic Clinical Talent and Domain Expertise Chirok brings a highly specialized team of clinical documentation specialists, coding professionals, auditors, and healthcare subject matter experts enhancing Sagility's clinical capabilities and leadership in provider operations.\"},{\"title\":\"General Updates\",\"summary\":\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health\",\"source\":\"NSE\",\"published\":\"21-Oct-2026 21:20:50\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212037_IntimationChirokAcquisitionsigned.pdf\",\"disclosure_text\":\"Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Date: October 21, 2026 To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C\/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir\/Madam, Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We wish to inform you that the Board of Directors of the Company at their meeting held on 21st October 2026, have proposed an acquisition\/investment by Sagility (US) Holdings Inc., a wholly owned subsidiary of Sagility Limited. Sagility (US) Holdings Inc., has signed a definitive agreement on 21 st October 2026, with Chirok Health LLC, the details of which are given as Annexure A to this letter, as required under the Listing Regulations read with SEBI Circular No. HO\/49\/14\/14(7)2025 -CFD- POD2\/I\/3762\/2026 dated January 30, 2026. Kindly take the above information on your record For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer Membership No: A16008 Place: Bengaluru Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Annexure A Details as required under SEBI Circular No. HO\/49\/14\/14(7)2025-CFD-POD2\/I\/3762\/2026 dated January 30, 2026 Sl. No. Particulars Details 1. Name of the target entity, details in brief such as size, turnover etc. Chirok Health LLC Turnover: US$ 9.0 M (CY2025) here hereafter mentioned as Chirok 2. Whether the acquisition would fall within related party transaction(s) and whether the promoter\/ promoter group\/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at \u201carm\u2019s length\u201d No 3 Industry to which the entity being acquired belongs. Healthcare services \/ Healthcare Revenue Cycle Management (RCM), including Clinical Documentation Integrity (CDI) and medical coding services. 4 Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity); The acquisition is intended to strengthen Sagility\u2019s capabilities in the provider segment by adding specialised Clinical Documentation Integrity (CDI), medical coding and revenue optimisation capabilities, complementing Sagility\u2019s existing healthcare servi ces portfolio. 5 Brief details of any governmental or regulatory approvals required for the acquisition NA 6 Indicative time-period for completion of the acquisition 21st October 2026 7 Consideration - whether cash consideration or share swap or any other form and details of the same Cash 8 Cost of acquisition and\/or the price at which the shares are acquired Aggregate purchase consideration of upto US$ 32.35 M, comprising: \u2022 Upfront payment of US$ 20.0 M at closing, subject to customary closing adjustments; and Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru \u2013 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com \u2022 Contingent consideration upto US$ 12.35 M, payable subject to achievement of specified performance milestones 9 Percentage of shareholding \/ control acquired and \/ or number of shares acquired 100% 10 Brief background about the entity acquired in terms of products\/line of business acquired, date of incorporation, history of last 3 years\u2019 turnover, country in which the acquired entity has presence and any other significant information (in brief) Chirok Health LLC is a US -based healthcare services company providing Clinical Documentation Integrity (CDI), medical coding, Revenue Cycle Management (RCM), and audit and quality assurance services, supported by its proprietary CHEMP workflow platform. The Company was incorporated in 2019 and is headquartered in Tennessee, United States. The Company has turnover of approximately USD 12.7 M, USD 8.2 M, and USD 9.0 M for CY2023, CY2024, and CY2025 respectively.\"},{\"summary\":\"a press release dated July 21, 2026, titled \\\"Press release pertaining to the unaudited financial results for the quarter ended June 30, 2026\\\".\",\"category\":\"Press Release\",\"date\":\"21-Jul-2026 18:38:20\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21072026183803_IntimationPressReleaseQ1FY27signed.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"SAGILITY LIMITED has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.\",\"category\":\"Outcome of Board Meeting\",\"date\":\"21-Jul-2026 18:31:18\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21072026183016_IntimationResultsQ1FY27signed.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"a press release dated October 21, 2026, titled \\\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health\\\".\",\"category\":\"Press Release\",\"date\":\"21-Oct-2026 21:25:15\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212509_IntimationPressReleasesigned.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":3},{\"summary\":\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health.\",\"category\":\"General Updates\",\"date\":\"21-Oct-2026 21:20:50\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212037_IntimationChirokAcquisitionsigned.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":3}],\"recent_news\":[{\"summary\":\"a press release dated October 22, 2026, titled \\\"Press release pertaining to unaudited financial results (standalone & consolidated) for the quarter ended September 30, 2026\\\".\",\"category\":\"Press Release\",\"date\":\"22-Oct-2026 18:44:34\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026184424_IntimationPressReleaseSigned.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"SAGILITY LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.\",\"category\":\"Outcome of Board Meeting\",\"date\":\"22-Oct-2026 18:37:59\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_22102026183617_IntimationResultsSigned.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"a press release dated October 21, 2026, titled \\\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health\\\".\",\"category\":\"Press Release\",\"date\":\"21-Oct-2026 21:25:15\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212509_IntimationPressReleasesigned.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":3},{\"summary\":\"Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health.\",\"category\":\"General Updates\",\"date\":\"21-Oct-2026 21:20:50\",\"source\":\"NSE filing\",\"industry\":null,\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SAGILITY_21102026212037_IntimationChirokAcquisitionsigned.pdf\",\"headline\":\"Investment \/ acquisition update\",\"impact\":\"The transaction can affect growth strategy, capital allocation or market access. Investors should consider the size of the investment, ownership acquired and expected returns.\",\"importance_score\":4,\"completeness_score\":3}],\"promoter_pledge\":{\"summary\":\"The promoter\/promoter-group disclosure states that the shares covered by the filing were free from encumbrance.\",\"events\":[{\"summary\":\"ge of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai \u2013 400 051 The Manager \u2013 DCS, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai \u2013 400001 Dear Sir(s), Sub.: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 I, SAGILITY B.V ., Promoter of the Sagility Limited (\u201cthe Company\u201d) on behalf itself and all other persons acting in concert with me, hereby declare and confirm that we have not made any encumbrance, directly or indirectly, other than those already disclosed during the financial year ended on 31st March, 2026 under Regulation 31 (4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Kindly take the same on record. Thanking You, For, Sagility B.V . ________________________________________ _____________________ Name: Vistra Management Services (Netherlands) B.V . Name: T. Bogaards Title: Director A (represented by T. Bogaards & Title: Director B W.E.G. Buijze as Proxyholder A & Proxyholder B, respectively) Docusign Envelope ID: 441B47B8-6A53-4E91-BA29-483410750176\",\"category\":\"Disclosure under SEBI Takeover Regulations\",\"date\":\"18-Jun-2026 17:25:38\",\"source\":\"NSE corporate filing\",\"attachment\":\"https:\/\/nsearchives.nseindia.com\/corporate\/team_sandeshc_16062026121542_29.pdf\",\"detail_level\":\"pdf_facts\"}],\"source\":\"NSE corporate filing\"},\"shareholding_snapshot\":{\"promoter_pct\":50.95,\"public_pct\":49.05,\"fii_pct\":10.38,\"dii_pct\":22.59,\"mf_pct\":15.13,\"institutional_pct\":32.97,\"noninst_pct\":16.08,\"mf_scheme_count\":33,\"pledged_shares\":null,\"pledged_pct_of_promoter\":null,\"mf_holders\":[{\"name\":\"ICICI Prudential Technology Fund\",\"shares\":158761940,\"pct\":3.39},{\"name\":\"Kotak Small Cap Fund\",\"shares\":86972029,\"pct\":1.86},{\"name\":\"Canara Robeco Mutual Fund A\/C Canara Robeco Small Cap Fund\",\"shares\":83285323,\"pct\":1.78},{\"name\":\"Axis Mutual Fund Trustee Limited A\/C Axis Mutual Fund A\/C Axis Small Cap Fund\",\"shares\":71407249,\"pct\":1.53}],\"period\":\"30-SEP-2026\",\"submission_date\":\"13-OCT-2026\",\"source\":\"NSE shareholding pattern XBRL\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1737173_13102026055925_WEB.xml\",\"previous_period\":\"30-JUN-2026\",\"previous_promoter_pct\":50.95,\"previous_fii_pct\":9.99,\"previous_dii_pct\":21.42,\"previous_mf_pct\":13.45,\"previous_institutional_pct\":31.41,\"previous_mf_scheme_count\":32,\"previous_pledged_pct_of_promoter\":null,\"previous_pledged_shares\":null}} --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sagility share price rose 2.21% to \u20b945.39 today. See why SAGILITY is rising, volume context, company developments and what to watch next.<\/p>\n","protected":false},"author":1,"featured_media":7117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Sagility Share Price Today: Why SAGILITY Is Rising 2.21% | 22 October 2026","_witty_meta_description":"Sagility share price rose 2.21% to \u20b945.39 today. See why SAGILITY is rising, volume context, company developments and what to watch next.","_witty_primary_phrase":"Sagility share price today","_witty_reason_label":"Positive earnings and corporate updates against a softer broader market","_witty_reason_confidence":"medium","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[210],"class_list":["post-7118","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-sagility"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/7118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=7118"}],"version-history":[{"count":4,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/7118\/revisions"}],"predecessor-version":[{"id":7416,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/7118\/revisions\/7416"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/7117"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=7118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=7118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=7118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}